(189 days)
Not Found
Not Found
No
The device description focuses on the laser technology and optical delivery system, with no mention of AI or ML capabilities, image processing, or data sets for training/testing.
Yes
The device is used for the "treatment" of vascular lesions, which indicates a therapeutic purpose.
No
This device is described as a laser system intended for surgical procedures such as incision, ablation, vaporization, coagulation, and hemostasis of soft tissue and vascular lesions, not for diagnosing conditions. Its description focuses on delivering therapeutic energy.
No
The device description clearly outlines hardware components including an optical cavity, Nd:YAG crystal, flashlamps, beamsplitter assembly, optical fiber delivery system, focusing handpiece, electronic power supply, interface circuitry, and an optical chamber. This is a hardware-based laser system, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. These tests are performed outside the body.
- Device Function: The Fotona Dualis KTP Laser System is a surgical laser intended for direct interaction with tissues within or on the body for procedures like incision, ablation, vaporization, coagulation, and hemostasis. It is used in a non-contact mode, but it is still directly treating the patient's tissues.
- Intended Use: The intended use clearly describes surgical procedures on various tissues and the treatment of vascular lesions, all of which are performed directly on the patient.
The description of the device and its intended use aligns with a surgical laser, not a device used for testing samples in a laboratory setting.
N/A
Intended Use / Indications for Use
The Fotona Dualis KTP (532 nm) laser system is indicated for incision, ablation, vaporization, coagulation, and hemostasis of vascular lesions and soft tissue in various surgical areas. All soft tissue is included, such as skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs, and glands.
Dermatology : The treatment (hemostasis, color lightening, blanching, flattening, reduction of lesion size) of the vascular lesions (Angiomas, Hemangiomas, Telangiectasia)
Product codes
GEX
Device Description
The Fotona Dualis KTP (532 nm) system is based on Nd:YAG laser technology. Within the system, an optical cavity contains the Nd: YAG crystal, which is activated by means of the use of flashlamps. After the cavity, a red diode aiming beam is reflected onto a coaxial beam path using a beamsplitter assembly. The combined therapuetic and aiming beams are guided down an optical fiber delivery system to a focusing handpiece. The laser is used in non-contact mode.
The Dualis KTP system is designed with 3 major sub-systems:
a) An optical delivery system, interfacing the energy from the laser to the patient via an optical fiber arm and a focusing handpiece.
b) An electronic power supply and interface circuitry.
c) An optical chamber containing laser rod and laser cavity optics.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs, and glands.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
:
Summary of Safety and Effectiveness Data
| I. General Information | DEC 2 7 2001 |
|---|---|
| Company : | Fotona d.d. |
| Stegne 7, 1210 Ljubljana, Slovenia | |
| Contact Person : | Mojca Valjavec |
| Preparation Date : | 06-11-01 |
| Device Trade Name : | Fotona Dualis KTP (532 nm) Laser System and |
| Accessories | |
| Common Name : | Frequency Doubled Nd:YAG Pulsed Surgical Laser |
| System | |
| Classification Name : | Instrument, Surgical, Powered, Laser |
| 79-GEX | |
| 21 CFR 878-4810 |
II. Description
The Fotona Dualis KTP (532 nm) system is based on Nd:YAG laser technology. Within the system, an optical cavity contains the Nd: YAG crystal, which is activated by means of the use of flashlamps. After the cavity, a red diode aiming beam is reflected onto a coaxial beam path using a beamsplitter assembly. The combined therapuetic and aiming beams are guided down an optical fiber delivery system to a focusing handpiece. The laser is used in non-contact mode.
The Dualis KTP system is designed with 3 major sub-systems:
a) An optical delivery system, interfacing the energy from the laser to the patient via an optical fiber arm and a focusing handpiece.
b) An electronic power supply and interface circuitry.
c) An optical chamber containing laser rod and laser cavity optics.
II. Intended Use
The Fotona Dualis KTP (532 nm) laser system is indicated for incision, ablation, vaporization, coagulation, and hemostasis of vascular lesions and soft tissue in various surgical areas. All soft tissue is included, such as skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs, and glands.
1
III. Summary of Substantial Equivalence
Fotona believes that its Dualis KTP (532 nm) system is substantially equivalent to the Coherent VersaPulse laser system, Laserscope Lyra laser system, and to other KTP (532 nm) lasers previously cleared for similar clinical applications.
All lasers are cleared for surgical incision, ablation, vaporization, coagulation, and hemostasis of vascular lesions and soft tissue in various surgical areas. All soft tissue is included, such as, skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs, and glands.
Technologically, the predicate devices have identical characteristics to the Dualis KTP (532 nm) laser, all three comprising an electronic control module and a flashlamp pumped Nd: YAG laser rod generating light at a wavelength of 532 um, which is subsequently delivered to the patient via an optical fiber and a focusing handpiece.
The Dualis KTP (532 nm) laser output characteristics are very similar to those of the predicate devices.
All lasers are microprocessor controlled devices.
All lasers utilize class I aiming beams which pose no hazard to the user.
All systems utilize an internal closed loop water-air heat exchanger circuit for optimal thermal control of the laser cavity.
The risk and benefits for the Fotona Dualis KTP (532 nm) are comparable to the predicate devices when used for similar clinical applications.
It is therefore believed that there are no new questions of Safety or Effectiveness raised by the introduction of this device.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its wings, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern around the eagle. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 2 7 2001
Mojca Valjavec Fotona D. D. Stegne 7 1210 Ljubljana Slovenia
Re: K011939 Trade Name: Fotona Dualis Regulation Number: 878.4810 Regulation Name: Instrument, Surgical, Powered, Laser Regulatory Class: II Product Code: GEX Dated: October 11, 2001 Received: October 11, 2001
Dear Ms. Valjavec:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 – Ms. Mojca Valjavec
This letter will allow you to begin marketing your device as described in your Section I has letter will anon you to of the FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 If you desire specific ad rise 10.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion orner of Companies and advice, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, (Misbranding by reference to premarket notification( (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 6382041 or (301) 4436597 or at its Internet address HYPERLINK http://www.fda.gov/cdrh/dsma/dsmamain.html http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
StipL Clurdu
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
APPENDIX F
Page 1 of 1
INDICATIONS FOR USE STATEMENT
K 011939 510(k) Number (if known):_
Device Name:
FOTONA DUALIS KTP (532 nm) LASER SYSTEM AND ACCESSORIES
Indications For Use:
The Fotona Dualis KTP (532 nm) Laser System and Accessories is intended for incision, ablation, vaporization, coagulation, and hemostasis of vascular lesions and soft tissue in various surgical areas. All soft tissue is included, such as skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs, and glands.
Dermatology :
The treatment (hemostasis, color lightening, blanching, flattening, reduction of lesion size) of the vascular lesions (Angiomas, Hemangiomas, Telangiectasia)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
OR
Prescription Use > (Per 21 CFR 801.109)
Over-The-Counter Use
Hye Purdn
Division Sign Off
(Division Sign-Off) Division of General, Restorati and Neurological Devices
510(k) Number_ KOU 939